Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGS2 | P35354 | 2/20 | 0.57 |
| ▸ | MEN1 | O00255 | 3/20 | 0.56 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.56 |
| ▸ | GAA | P10253 | 3/20 | 0.56 |
| ▸ | RAB9A | P51151 | 2/20 | 0.56 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.56 |
| ▸ | NPC1 | O15118 | 1/20 | 0.56 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.56 |
| ▸ | MAOB | P27338 | 1/20 | 0.55 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.53 |
| ▸ | SLC22A8 | Q8TCC7 | 1/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.52 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.52 |
| ▸ | TRIM24 | O15164 | 1/20 | 0.52 |
| ▸ | HPGD | P15428 | 1/20 | 0.52 |
| ▸ | ALDH5A1 | P51649 | 1/20 | 0.52 |
| ▸ | ABAT | P80404 | 1/20 | 0.52 |
| ▸ | TRIM33 | Q9UPN9 | 1/20 | 0.52 |
| ▸ | HTT | P42858 | 1/20 | 0.52 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12844550 | 0.84 | PTGS1 (0.57) | PTGS2GAAALDH1A1MAPTPTGS1 | |
| SCHEMBL279706 | 0.81 | HTR3E (0.59) | PTGS2MEN1KMT2AGAARAB9A | |
| SCHEMBL9499701 | 0.79 | MEN1 (0.58) | PTGS2MEN1KMT2AGAARAB9A | |
| SCHEMBL28210948 | 0.79 | PIM1 (0.44) | PTGS2MEN1KMT2AGAARAB9A | |
| SCHEMBL12154783 | 0.78 | HTR3E (0.41) | PTGS2MEN1KMT2AALDH1A1MAPT | |
| SCHEMBL11547404 | 0.77 | KMT2A (0.39) | PTGS2MEN1KMT2AGAARAB9A | |
| SCHEMBL12738623 | 0.76 | AMY1A (0.44) | KMT2AGAARAB9AALDH1A1HPGD | |
| SCHEMBL7065017 | 0.76 | ALDH1A1 (0.55) | PTGS2MEN1KMT2AGAAL3MBTL1 | |
| SCHEMBL13586979 | 0.76 | ALDH1A1 (0.44) | MEN1KMT2AGAAL3MBTL1NPC1 | |
| SCHEMBL12565706 | 0.76 | MEN1 (0.73) | PTGS2MEN1KMT2AGAARAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-4425404-A | MULTILAYER, PROTECTIVE COATINGS | MATSUSHITA ELECTRIC INDUSTRIAL CO., LTD. (JP) | 1984-01-10 | — | — | US | claimed |
| US-20250263384-A9 | REDOX-ACTIVE COMPOUNDS AND USES THEREOF | CMBLU ENERGY AG (DE) | 2025-08-21 | — | — | US | disclosed |
| US-20240124405-A1 | REDOX-ACTIVE COMPOUNDS AND USES THEREOF | CMBLU PROJECKT AG (DE) | 2024-04-18 | — | — | US | disclosed |
| US-11731945-B2 | Redox-active compounds and uses thereof | CMBLU ENERGY AG (DE) | 2023-08-22 | — | — | US | disclosed |
| US-11731945-B2 | Redox-active compounds and uses thereof | CMBLU ENERGY AG (DE) | 2023-08-22 | — | — | US | disclosed |
| US-11731945-B2 | Redox-active compounds and uses thereof | CMBLU ENERGY AG (DE) | 2023-08-22 | — | — | US | disclosed |
| US-20210253540-A1 | REDOX-ACTIVE COMPOUNDS AND USES THEREOF | CMBLU PROJEKT AG (DE) | 2021-08-19 | — | — | US | disclosed |
| US-20210253540-A1 | REDOX-ACTIVE COMPOUNDS AND USES THEREOF | CMBLU PROJEKT AG (DE) | 2021-08-19 | — | — | US | disclosed |
| CN-113166079-A | Redox active compounds and their use | 克姆布鲁项目公司 | 2021-07-23 | — | — | CN | disclosed |
| EP-3837246-A2 | REDOX-ACTIVE COMPOUNDS AND USES THEREOF | CMBlu Projekt AG (DE) | 2021-06-23 | — | — | EP | disclosed |
| WO-2012074536-A1 | PROCESS FOR THE PREPARATION OF 2-METHOXYMETHYL-1,4-BENZENEDIAMINE, ITS DERIVATIVES THEREOF AND THE SALTS THEREOF | THE PROCTER & GAMBLE COMPANY (US) | 2012-06-07 | — | — | WO | disclosed |
| US-20120142969-A1 | Process for the Preparation of 2-Methoxymethyl-1,4-Benzenediamine, Its Derivatives Thereof and the Salts Thereof | WELLA OPERATIONS US, LLC | 2012-06-07 | — | — | US | disclosed |
| US-7851501-B2 | Aromatic nitrocatechol compounds and their use for modulating processes mediated by cell adhesion molecules | REVOTAR BIOPHARMACEUTICALS AG (DE) | 2010-12-14 | — | — | US | disclosed |
| US-20090105280-A1 | Novel Aromatic Nitro Compounds | REVOTAR BIOPHARMACEUTICALS AG (DE) | 2009-04-23 | — | — | US | disclosed |
| US-7514556-B2 | Inhibitors of β-lactamase | METHYLGENE INC. (CA) | 2009-04-07 | — | — | US | disclosed |
| EP-0229014-B1 | MAGNETIC RECORDING MEDIUM | SONY CORPORATION (JP) | 1993-03-24 | — | — | EP | disclosed |
| US-4735848-A | PERFLUOROALKYL ESTER LUBRICANT | SONY CORPORATION (JP) | 1988-04-05 | — | — | US | disclosed |
| EP-0229014-A2 | Magnetic recording medium | SONY CORPORATION (JP) | 1987-07-15 | — | — | EP | disclosed |
| US-4425404-A | MULTILAYER, PROTECTIVE COATINGS | MATSUSHITA ELECTRIC INDUSTRIAL CO., LTD. (JP) | 1984-01-10 | — | — | US | disclosed |
| EP-0093194-A2 | Magnetic recording medium | MATSUSHITA ELECTRIC INDUSTRIAL CO., LTD. (JP) | 1983-11-09 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240124405-A1 | REDOX-ACTIVE COMPOUNDS AND USES THEREOF | NOX4, NQO1, GPX1 | PTGS2 1546/4885MEN1 4552/4885KMT2A 1859/4885 |
| US-20120142969-A1 | Process for the Preparation of 2-Methoxymethyl-1,4-Benzenediamine, Its Derivatives Thereof and the Salts Thereof | KRT18, VIM, KDM4B | PTGS2 2488/4885MEN1 2670/4885KMT2A 157/4885 |
| US-20090105280-A1 | Novel Aromatic Nitro Compounds | SELP, SELE, SELL | PTGS2 734/4885MEN1 4614/4885KMT2A 3098/4885 |
| US-20250263384-A9 | REDOX-ACTIVE COMPOUNDS AND USES THEREOF | NOX4, NQO1, GPX1 | PTGS2 1546/4885MEN1 4552/4885KMT2A 1859/4885 |
| US-11731945-B2 | Redox-active compounds and uses thereof | NOX4, NQO1, GPX1 | PTGS2 1546/4885MEN1 4552/4885KMT2A 1859/4885 |
| US-20210253540-A1 | REDOX-ACTIVE COMPOUNDS AND USES THEREOF | NOX4, NQO1, GPX1 | PTGS2 1546/4885MEN1 4552/4885KMT2A 1859/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.